Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | XmAb13676 |
Trade Name | |
Synonyms | Plamotamab |
Drug Descriptions |
XmAb13676 (Plamotamab) is a bispecific monoclonal antibody that targets CD20-expressing B cells and CD3-expressing T cells, and once bound may potentially result in T-cell mediated cytotoxicity of tumor cells (Blood 2014 124:3111). |
DrugClasses | CD20 Antibody 24 CD3 Antibody 99 |
CAS Registry Number | 2138442-31-4 |
NCIT ID | C130050 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Lenalidomide + Tafasitamab-cxix + XmAb13676 | Lenalidomide Tafasitamab-cxix XmAb13676 | 0 | 1 |
XmAb13676 | XmAb13676 | 0 | 1 |